Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicine, announced today the publication of foundational research demonstrating the power of its proprietary ...

Information sessions are scheduled for Wednesday about Lincoln Land Community College-Jacksonville's program to help ...

NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...

The Camp Davis Rocky Mountain Field Station, a research and teaching facility about 30 miles south of Jackson, Wyoming, will ...

The National Transportation Safety Board has released its preliminary report on the October plane crash in Bath Township that ...

A Fort Lauderdale city commissioner and the dean of Nova Southeastern University’s Guy Harvey Oceanographic Research Center ...

Medley Therapeutics, Inc. (formerly YAP Therapeutics), a company developing regenerative genetic medicines and advanced biologics, today announced completion of dosing in the first cohort (n=3) of the ...

CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...

Below you'll find MLA Tim McLeod and MLA Megan Patterson's Report from the Legislature for November 12, 2025. The views expressed below are solely the opinions of the authors and do not necessarily ...

A computational study published in the Journal of Molecular Liquids makes important contributions to the development of new, ...

Panelists discuss how emerging therapies like menin inhibitors show promise based on strong preclinical data and clinical responses, while CD47 inhibitors have faced setbacks in phase 3 trials, with ...

Even as HRMC celebrates its 75th Anniversary, local health care leaders have their eyes on the future and expanding Hampton ...